NYSE: NOCNorthrop Grumman Corp Stock
$488.06+13.49 (+2.84%)
Updated Apr 25, 2024
NOC Price
$488.06
Fair Value Price
N/A
Market Cap
$72.23B
52 Week Low
$414.56
52 Week High
$496.89
P/E
33.92x
P/B
5.08x
P/S
1.78x
PEG
0.48x
Dividend Yield
1.53%
Revenue
$40.12B
Earnings
$2.16B
Gross Margin
16.7%
Operating Margin
7.58%
Profit Margin
5.4%
Debt to Equity
2.36
Operating Cash Flow
$4B
Beta
0.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NOC Overview
Northrop Grumman Corporation manufactures unmanned autonomous aircraft systems (e.g., high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems), and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, as well as airborne battle management and command and control systems. The company also develops and produces other weapons and mission systems controls (e.g., munitions and missiles, precision strike weapons, air-breathing and hypersonic systems, and gun systems). Northrop Grumman was founded in 1939 and is headquartered in Falls Church, VA.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NOC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NOC ($488.06) is trading above its intrinsic value of $434.83, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NOC is good value based on its earnings relative to its share price (33.92x), compared to the US market average (40.97x)
P/E vs Market Valuation
NOC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NOC due diligence checks available for Premium users.
Be the first to know about important NOC news, forecast changes, insider trades & much more!
NOC News
Valuation
NOC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
33.92x
Industry
24x
Market
40.97x
NOC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NOC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NOC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.08x
Industry
5.36x
NOC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NOC price to earnings growth (PEG)
For valuing profitable companies with growth potential
NOC is good value based... subscribe to Premium to read more.
PEG Value Valuation
NOC's financial health
Profit margin
Revenue
$10.1B
Net Income
$944.0M
Profit Margin
9.3%
NOC's Earnings (EBIT) of $3.04B... subscribe to Premium to read more.
Interest Coverage Financials
NOC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$47.8B
Liabilities
$33.6B
Debt to equity
2.36
NOC's short-term assets ($14.80B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NOC's long-term liabilities ($20.46B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NOC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NOC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$706.0M
Investing
-$269.0M
Financing
$927.0M
NOC's operating cash flow ($3.87B)... subscribe to Premium to read more.
Debt Coverage Financials
NOC vs Defense Stocks
Northrop Grumman Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.